好色先生

好色先生

Explore the latest content from across our publications
Join The AAN

Log In

Forgot Password?
Create New Account

Loading... please wait

2019 Annual Meeting | S54 - Motor Neuron Disease

Thursday 05/09/19
03:30 PM - 05:30 PM EDT Add To Calendar
This program will be presented both in-person and online
This program is not expected to be available in the meeting's On Demand product.
Scientific Platform Session
Justin Y. Kwan, MD, FAAN, Anahita F. Deboo, MD
Neuromuscular and Clinical Neurophysiology (EMG)
2.00 CME credits

Program Materials Program Evaluations

Event Timeline
03:30 PM - 03:41 PM EDT Abstract 001 - Heritability of ALS: A Population-based study over 24 years.
03:41 PM - 03:52 PM EDT Abstract 002 - The Clinical and Neuroimaging Features of Primary Lateral Sclerosis
Eoin Finegan, MBBS
03:52 PM - 04:03 PM EDT Abstract 003 - Clinical findings in amyotrophic lateral sclerosis type 4
Christopher Grunseich, MD
04:03 PM - 04:14 PM EDT Abstract 004 - Pathological and Behavioral Characterization of Transgenic Mice Expressing ALS-Associated CHCHD10-R15L
Eanna Barra Ryan
04:14 PM - 04:25 PM EDT Abstract 005 - Distinct patterns of cerebellar damage in sporadic and C9ORF72-related ALS
Fabricio C. Borba, MD
04:25 PM - 04:36 PM EDT Abstract 006 - A Novel Muscle Cramp Scale for Patients with ALS
Hiroshi Mitsumoto, MD, FAAN
04:36 PM - 04:47 PM EDT Abstract 007 - Correlation of cognitive impairment and KING’s and MiTos staging in ALS: a cross-sectional population-based study.
Rosario Vasta, MD
04:47 PM - 04:58 PM EDT Abstract 008 - Differentially Expressed microRNA Profile in Skeletal Muscle Tissue of Sporadic ALS Patients
Evrim Aksu-Menges
04:58 PM - 05:09 PM EDT Abstract 009 - Retrospective review of respiratory function in the Amyotrophic Lateral Sclerosis(ALS) veteran population with and without Edaravone therapy.
05:10 PM - 05:30 PM EDT Q&A Q&A Panel with Authors
Faculty Disclosures
Justin Y. Kwan, MD, FAAN Dr. Kwan has received research support from National Institutes of Health. Dr. Kwan has received personal compensation in the range of $100,000-$499,999 for serving as a Employee with National Institutes of Health.
Anahita F. Deboo, MD Dr. Deboo has nothing to disclose.
No disclosure on file
Eanna Barra Ryan No disclosure on file
Can Ebru Kurt, MD Can Ebru Kurt, MD has nothing to disclose.
Mohammad Salajegheh, MD, FAAN Dr. Salajegheh has received personal compensation in the range of $100,000-$499,999 for serving as a Employee with US Department of Veterans Affairs.
Evrim Aksu-Menges Ms. Aksu-Menges has nothing to disclose.
Nikita James No disclosure on file
Thiago Rezende No disclosure on file
Gabriele Mora, MD Dr. Mora has nothing to disclose.
Lucas D. Branco No disclosure on file
Kenneth H. Fischbeck, MD, FAAN Dr. Fischbeck has received research support from NINDS/NIH. Dr. Fischbeck has received intellectual property interests from a discovery or technology relating to health care. Dr. Fischbeck has a non-compensated relationship as a Scientific Review Board member with Kennedy's Disease Association that is relevant to AAN interests or activities. Dr. Fischbeck has a non-compensated relationship as a Scientific Council member with Association Francaise contre les Myopathies that is relevant to AAN interests or activities. Dr. Fischbeck has a non-compensated relationship as a Independent Review Committee member with Target ALS that is relevant to AAN interests or activities. Dr. Fischbeck has a non-compensated relationship as a Scientific Advisory Board member, Musculoskeletal Diseases with Novartis that is relevant to AAN interests or activities. Dr. Fischbeck has a non-compensated relationship as a Senior Clinical Consultant with n-Lorem Foundation that is relevant to AAN interests or activities. Dr. Fischbeck has a non-compensated relationship as a Scientific Advisory Committee member with Stanford GNE myopathy program that is relevant to AAN interests or activities. Dr. Fischbeck has a non-compensated relationship as a Scientific Advisory Board member with Hereditary Disease Foundation that is relevant to AAN interests or activities. Dr. Fischbeck has a non-compensated relationship as a Scientific Advisory Board member with Packard Center for ALS Research that is relevant to AAN interests or activities. Dr. Fischbeck has a non-compensated relationship as a Scientific Advisory Board member with Huntington's Disease Society of America that is relevant to AAN interests or activities. Dr. Fischbeck has a non-compensated relationship as a TACT review panel member with TREAT-NMD that is relevant to AAN interests or activities.
Niall Pender, PhD No disclosure on file
Jianhua Yan, PhD No disclosure on file
Marcondes C. Franca, Jr., MD Dr. Franca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer. Dr. Franca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PTC. Dr. Franca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Franca has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. The institution of Dr. Franca has received research support from FARA.
Umberto Manera, MD Dr. Manera has nothing to disclose.
Fabricio C. Borba, MD No disclosure on file
Colette G. Donaghy, MD Colette G. Donaghy, MC MRCP has nothing to disclose.
Eoin Finegan, MBBS Dr. Finegan has nothing to disclose.
Rosario Vasta, MD Dr. Vasta has nothing to disclose.
Adriano Chio, MD, FAAN Dr. Chio has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cytokinetics. Dr. Chio has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mitsubishi. Dr. Chio has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Chio has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Corcept.
Ibrahim Laleka No disclosure on file
Orla Hardiman, MD, FRCPI, FAAN Dr. Hardiman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Wave Pharmaceuticals. Dr. Hardiman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cytokinetics . Dr. Hardiman has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Hardiman has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Taylor and Francis. The institution of Dr. Hardiman has received research support from Science Foundation Ireland. The institution of Dr. Hardiman has received research support from HRB.
Peter Bede, MD, PhD Dr. Bede has nothing to disclose.
Han-Xiang Deng, MD Dr. Deng has nothing to disclose.
Ersin Tan, MD Dr. Tan has nothing to disclose.
Andrea Calvo, MD, PhD, FAAN Dr. Calvo has nothing to disclose.
Cristina Moglia Cristina Moglia has nothing to disclose.
Barbara Iazzolino Barbara Iazzolino has nothing to disclose.
Christopher Grunseich, MD Dr. Grunseich has nothing to disclose.
Hiroshi Mitsumoto, MD, FAAN Dr. Mitsumoto has nothing to disclose.
Teepu Siddique, MD, FAAN No disclosure on file
Antonio Canosa Antonio Canosa has nothing to disclose.
Letizia Mazzini No disclosure on file